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Abstract
Pain has the capacity to interfere with daily tasks. Although task interference by pain is largely unintentional, it can be controlled to
a certain extent. Such top-down control over pain has been believed to be reduced in patients with fibromyalgia (FM). In this study,
we investigated task interference and distraction efficacy in patients with FM and a matched healthy control group. Forty-nine
patients with FM and 49 healthy volunteers performed as quickly as possible (1) a visual localization task in the presence of
nonpainful vibrating or painful electric somatic stimuli, and (2) a somatosensory localization task (using nonpainful or painful stimuli).
Participants reported on their experience of the somatic stimuli on some of the trials during both localisation tasks. Results indicated
that pain interferes with performance of the visual task, in both patients with FM and healthy individuals. Furthermore, participants
experienced the pain stimulus as less intense when directing attention away from the pain than when focusing on the pain. Overall,
task performance of patients with FMwas slower comparedwith the task performance in the healthy control group. In contrast to our
hypotheses, patients with FM and healthy volunteers did not differ in themagnitude of the interference effect and distraction efficacy.
In conclusion, current study provides support for contemporary theories claiming that attention modulates the experience of pain
and vice versa. However, no evidence was found for an altered attentional processing of pain in patients with FM. Furthermore,
results indicate that task interference and distraction efficacy are not just 2 sides of the same coin.
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1. Introduction
A key feature of pain is its ability to demand attention.15,57 In acute
pain, this feature is adaptive because it urges a person to escape
from bodily threat.15 In the long term, however, this ability may
become maladaptive because pain interferes with the capability
to fulfil daily tasks and goal pursuit.16,18,49 The interference of pain
with task performance has been documented in healthy
individuals experiencing acute pain3,6,9,35 as well as in those with
chronic pain.14,37 Although the capture of attention by pain may
be largely unintentional, it can be controlled to some extent.
Indeed, several studies have shown that directing attention away
from pain by engaging in a task unrelated to pain (ie, attentional
distraction) reduces acute pain and related distress.5,7,17,23,24,33
The answers to the questions “How and when does pain
interfere with ongoing tasks” (task interference), and “how and
when does directing attention away from pain diminishes pain
(distraction efficacy)” are often grounded in similar theoretical
frameworks.10,15,29 Nevertheless, only few studies have simulta-
neously investigated task interference and distraction efficacy
(see Ref. 42 for an exception). Furthermore, these frameworks
often (implicitly or explicitly) assume that the magnitude of both
phenomena is altered in people with chronic pain.19,29,37
Research comparing task interference and/or distraction efficacy
between healthy participants and patients with chronic pain is,
however, largely lacking. The need for further research comparing
both phenomena has been emphasised in a recent meta-
analysis, summarizing available work on the effects of distraction
in patients with chronic pain.54 In contrast to research in healthy
volunteers, available research in patients with chronic pain
suggests that directing attention away from pain does not reduce
pain and distress. Notwithstanding, more research study is
needed because the available evidence consisted largely of
studies that did not include healthy control groups, used small
samples, and suffered frommethodological shortcomings (eg, no
control for alternative coping strategies in the control condition). If
proven, distraction inefficacy in patients with chronic pain may
point at the presence of (1) heightened levels of vigilance for pain
and/or somatic sensations in general11,12,57 or (2) problems of
executive functioning in patients with chronic pain.4,37 Both
explanations have been put forward to explain the failure of
distraction in patients with chronic pain.25,28,56
In the current study, we investigated, both, task interference
and distraction efficacy in a sample of patients with fibromyal-
gia (FM) and amatched healthy control group. Patients with FM
were selected because previous research suggests that they
are prone to impairments of attention and show reduced levels
of executive functions.47 We hypothesized that (1) pain would
interfere with task performance in healthy participants and
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patients with FM, albeit to a larger extent in patients with FM;
(2) directing attention away from pain would reduce the
experience of pain in healthy volunteers, but not or to a lesser
extent in patients with FM; and (3) pain intensity would affect
the magnitude of task interference and distraction efficacy. For
exploratory purposes, we also examined the relationship
between distraction efficacy, task interference, and their
relationship with other constructs presumed to be play a role
in both phenomena.
2. Method
2.1. Participants
The study sample (N 5 98) consisted of patients with FM (N 5
49) and healthy volunteers (N 5 49) aged between 18 and 65
years, who were recruited for the ASEF-I-project. Within the
ASEF-I-project, a group of patients with FM and a matched
group of healthy participants were recruited to investigate
attention and self-regulatory processes. The full project
protocol, detailing the study design and flow can be retrieved
through the following link: http://hdl.handle.net/1854/LU-
5686902. Recruitment of participants took place between
January and March 2014. Participants were only included if
they (1) had sufficient knowledge of the Dutch language; (2) did
not suffer from a neurological condition; (3) could use both
index fingers; (4) did not report abnormal sensations in the
arms; (5) had a normal or corrected-to-normal (eg, by glasses)
eyesight; (6) were not pregnant; and (7) did not have
a pacemaker. In addition, patients with FM were only included
if they had received an FM diagnosis and fulfilled the American
College of Rheumatology (ACR)-2010-criteria,58 and healthy
participants if they did not report a current pain problem.
Patients with FM and healthy participants were matched at
group level for age, sex, and educational level. Patients with
FM were recruited in the Multidisciplinary Pain Clinic of Ghent
University Hospital. They were informed about the study
through a poster in the waiting room of the hospital. Patients
who were interested in taking part left their contact details. The
healthy control group was recruited through advertisements in
a local newspaper, flyers, and the university website. Healthy
participants who fulfilled the eligibility criteria were contacted
by telephone and informed about the study. For participants
who agreed to participate, an appointment was scheduled for
a laboratory session. A flow chart indicating the exact number
and reasons of nonparticipation of participants can be found in
the full study protocol of the ASEF-I-project. The study was
approved by the medical ethics committee of the University
Hospital of Ghent (registration number: 2013/1016).
2.2. Apparatus and somatosensory stimuli
Somatosensory stimuli consisted of painful and nonpainful
stimuli. Nonpainful stimuli were tactile stimuli (frequency 5 200
Hz; duration 5 300 ms; and intensity 5 0.07 W) and presented
with 2 resonant-type tactors (C-2 TACTOR; Engineering
Acoustics, Inc, Casselberry, FL) consisting of a box of 3.05
cm diameter and 0.79 cm height, with a skin contactor of 0.76
cm diameter. Painful stimuli were electrocutaneous stimuli
(bipolar; 50 Hz; 300 ms; instantaneous rise and fall time)
delivered by a constant current stimulator (DS5; Digitimer Ltd,
Hertfordshire, United Kingdom). All somatosensory stimuli were
delivered in the region of the medial cutaneous nerve of the left
forearm (close to the wrist or close to the elbow; Fig. 1).
2.3. Self-report measures
Fibromyalgia symptoms were assessed using the widespread
pain index (WPI) score, which represents a number of whole-
body pain areas (max score5 19), and the symptom severity (SS)
score that quantifies SS on a 0 to 12 scale by scoring problems
with fatigue, cognitive dysfunction, and unrefreshed sleep over
the past week. In line with the 2010 ACR criteria,58 participants
satisfied the FM criteria if they had a (1) WPI score greater than or
equal to 7 and an SS score greater than or equal to 5 or (2) a WPI
score ranging from 3 to 6 and an SS score greater than or equal
to 9.
Pain severity was assessed with the pain severity subscale of
the Multidimensional Pain Inventory (MPI26,31). The MPI (part 1)
consists of 5 subscales assessing the impact of pain on a 7-point
Likert scale ranging from 0 to 6. Pain severity was assessedwith 2
items (ie, “Rate the level of your pain at the present moment” and
“On average, how severe has your pain been during the last
week?”). In line with previous studies, the third item (“How much
suffering do you experience because of your pain?”) of the pain
severity subscale was not taken into account given that its
content relates to suffering rather than pain severity (see also
Refs. 40 and 53). The MPI has shown good reliability and
validity.43 In this study, Cronbach’s alpha of the MPI severity
subscale was 0.84.
Pain-related disability was measured with the Pain Disability
Index (PDI41) which assesses the level of restriction in participa-
tion in 7 life domains (eg, family) on a scale ranging from 0 (no
disability) to 10 (total disability). Participants were asked to
evaluate the overall impact of pain (not just when pain is at its
worst) on each of the 7 life domains, on a scale from 0 to 70.
Cronbach’s alpha of the PDI was 0.82.
Depressive mood, anxiety, and stress during the past week
were assessed using the Depression Anxiety Stress Scales
(DASS32). Each subscale contains 14 items (eg, “I found it hard to
wind down” and “I felt I was pretty worthless”), which were rated
on a 4-point Likert scale ranging from 0 (“did not apply to me at
all”) to 3 (“applied to me very much, or most of the time”). In this
study, Cronbach’s alpha for the depression, anxiety, and stress
subscales were, respectively, 0.96, 0.91, and 0.95.
Pain catastrophizing was assessed using the Pain Catastroph-
izing Scale (PCS46). This scale contains 13 items that measure
catastrophic thoughts about pain in both clinical and nonclinical
samples. To answer these items, participants are required to
think about past painful experiences and indicate on a 5-point
scale (ranging from 0 [“not at all”] to 4 [“always”]) the degree to
which they experienced each of the 13 thoughts or feelings (ie,
“When I’m in pain it’s terrible and I think it’s never going to get any
better”). Research has shown that the PCS is valid and reliable.48
In this study, Cronbach’s alpha of the total PCS score was 0.95.
Vigilance for bodily symptoms was measured using the Body
Vigilance Scale (BVS44). The BVS is a 4-item questionnaire
measuring vigilance for bodily symptoms on an 11-point
numerical rating scale (eg, “I am very sensitive to changes in my
internal body sensations”). The last item is an average of the
awareness scores of 15 nonspecific body symptoms (eg, “rate
how much attention you pay to each of the following sensations
[eg, heart palpitations, tingling, and nausea]”). Cronbach’s alpha
of the 4 BVS items in this study was 0.73.
2.4. Experimental task
The experimental task was programmed and presented using
INQUISIT Millisecond software package (Inquisit 3; Millisecond
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Software, Seattle, WA) on a Dell computer (Intel Core2 Duo
P8600, 4096MB) with a 60-Hz, 17-inch colour CRTmonitor. The
experiment consisted of localizing either the somatosensory
stimuli (nonpainful, low painful, and moderately painful) during
a somatosensory localisation task (somatosensory focus task), or
the visual stimuli during a visual localisation task (visual focus task
5 distraction task). Somatosensory and visual stimuli were
simultaneously presented during each trial. In 50% of the trials,
participants were instructed to localize as quickly as possible
whether the visual stimulus (ie, 1 3 1 cm black square) was
presented to the left or right side of the screen (visual focus trials).
On the remaining trials, participants were instructed to localize as
quickly as possible whether the somatosensory stimulus was
presented to the left (close to the elbow) or right (close to thewrist)
location on the left arm (somatosensory focus trials). Each trial
started with a visual cue consisting of a full coloured circle (either
blue or yellow; 1000 ms duration) in the centre of the screen that
indicatedwhichmodality was relevant and needed to be attended
to. Somatosensory and visual stimuli were presented the same
number of times at the left and right location. A total of 256 trials
were presented. In 192 (75%) trials, the somatosensory stimulus
consisted of nonpainful tactile stimuli. In the other 64 (25%) trials,
the somatosensory stimulus consisted of painful electrocuta-
neous stimuli (32 trials with low intense pain and 32 trials with
moderately intense pain). Furthermore, 25% of the nonpainful
trials (ie, 48 trials) and 75% of the painful trials (ie, 48 trials) were
followed by 2 visual analogue scales (VAS) (“How intense was the
last somatosensory stimulus” [0 5 totally not intense; 10 5 very
intense]; “How unpleasant was the last somatosensory stimulus”
[0 5 totally not unpleasant; 10 5 very unpleasant]) that probed
the intensity and the unpleasantness of the experienced pain.
Trials with vibrotactile stimuli were implemented for several
reasons. First, somatosensory trials were included as a control
category to investigate the magnitude of task interference by
pain. Second, the inclusion of somatosensory trials reduced the
overall percentage of trials that were followed by a pain rating.
Hence, the possibility that participants attended to the somato-
sensory stimuli during visual modality trials because they
expected to rate the somatosensory stimuli was kept low (see
also Ref. 51). This resulted in 6 trial types: (1) nonpainful
somatosensory focus trials, (2) low painful somatosensory focus
trials, (3) moderately painful somatosensory focus trials, (4)
nonpainful visual focus trials, (5) low painful visual focus trials,
and (6) moderately painful visual focus trials. Each trial type was
presented “equi-probably” and randomly at the left and right
location. Participants indicated the location of the stimuli using
the right hand on the keyboard (45 left; 65 right) (see Fig. 1 for
a schematic presentation of the study set-up).
2.5. Procedure
Before the experimental session (ie, before scheduling the
laboratory session and providing general study information), all
participants were asked to complete a number of questionnaires
at home (including the MPI, DASS, PDI, BVS, PCS, and
demographic information), either online (through LimeSurvey) or
on paper. On arrival, all participants received additional in-
formation about the study and signed an informed consent form.
Thereafter, all participants performed several experimental tasks
as part of the ASEF-I-project. The experimental task described in
the current study was the first (after ACR-criteria assessment and
a 10-minute resting period during which heart rate was
monitored) that people performed. Before starting the exper-
imental task, participants filled out how intense the pain was (VAS
ranging from 0 5 no pain to 100 5 worst imaginable pain) and
how much fatigue (VAS ranging from 05 not at all to 1005 very
much) they experienced at that moment. Furthermore, partic-
ipants received the following information “During this task,
Figure 1. Schematic illustration of the experimental set-up.
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nonpainful and painful stimuli will be administered. The intensity of
the stimuli may differ more or less from each other.” After
receiving this information, the left arm of the participants was
scrubbed and 2 lubricated Technomed Europe surface electro-
des (Maastricht, the Netherlands; 1 cm diameter) and 2 resonant-
type tactors (C-2 TACTOR; Engineering Acoustics, Inc) were
attached at 2 locations of the left forearm (close to the wrist or the
elbow) situated in the medial cutaneous nerve area. Next, the
intensity of the electrocutaneous stimuli was individually de-
termined for each participant by administering electrocutaneous
stimuli of increasing intensity at both locations of the arm (starting
with 0.5 mA) and increasing with steps of 0.5 mA. During the
calibration phase, participants were instructed to pay close
attention to the pain stimulus when judging its intensity. The
intensity of the electrocutaneous stimulus increased until
participants reported that the pain stimulus they received was
of moderate pain (on a scale ranging from “no pain,” “little pain,”
“moderate pain,” “intense pain,” “enormous pain,” and “unbear-
able pain”). This moderately intense pain stimulus was then used
during the experimental task. A so-called “low intense pain”
stimulus was derived from the moderately intense pain stimulus
using the formula provided by Arntz and Lousberg.2 This
procedure resulted in an overall mean objective stimulus intensity
of 3.79 mA (SD5 2.02) and 3.56 mA (SD5 1.97) for the left and
right moderately intense pain stimulus, respectively, and an
overall mean objective stimulus intensity of 3.38 mA (SD 5 1.82)
and 3.18 mA (SD 5 1.78) for the left and right low intense pain
stimulus. The objective stimulus intensity did not differ signifi-
cantly between locations (All F(1, 96) , 2.35 ns), but did differ
between groups (moderately intense pain stimulus: F(1, 96) ,
28.25, P, 0.001; low intense pain stimulus: F(1, 96), 28.03, P,
0.001), indicating that the objective intensity of the pain stimuli
was lower for patients with FM (moderately intense pain stimulus:
M 5 2.79 mA, SD 5 1.35; low intense pain stimulus: M 5
2.49mA, SD5 1.22) than for healthy controls (moderately intense
pain stimulus: M 5 4.56 mA, SD 5 1.89; low intense pain
stimulus: M 5 4.07 mA, SD 5 1.71).
2.6. Data analyses
Statistical analyses were performed with SPSS statistical
software, version 24.0 for Windows (SPSS Inc, Chicago, IL).
Analyses investigating task interference by pain in healthy
participants and patients with FM were performed on the
response latencies of distraction (ie, performance of the visual
task) trials only, using a repeated-measures analysis of variance
(ANOVA) with somatosensory stimulus (nonpainful vs low painful
vsmoderately painful) and group (healthy controls vs patients with
FM) as a between-group factor. Contrast analyses were used to
investigate the effect of pain intensity on the magnitude of task
interference. Analyses investigating distraction efficacy in healthy
participants and patients with FM were performed on pain
intensity and unpleasantness ratings of the painful stimuli only.
Pain intensity and unpleasantness ratings of the vibrotactile
stimuli were not analyzed (see above). For each dependent
variable (pain intensity and unpleasantness), a repeated-
measures ANOVA with Pain Stimulus (low painful vs moderately
painful) and Modality Relevance (somatosensory relevant vs
visual relevant) as within-subject factors and Group (healthy
controls vs patients with FM) as between-group factor was
conducted. When appropriate, contrast analyses were used.
For all analyses, Greenhouse–Geisser corrections (with ad-
justed degrees of freedom) were performed whenever the
sphericity assumption was violated (Mauchly test of sphericity
was P, 0.05). Furthermore, the cutoff for statistical significance
was set at P , 0.05, and effect sizes were reported using the
partial eta squared index (h2p) and when appropriate Cohen’s
d (see also Refs. 8, 27, and 39).
3. Results
3.1. Descriptives
Mean age of participants was 45.30 years (SD5 10.74; range 22-
65 years), and 81 of them were female (82.7%) (Table 1). The
majority of the participants wasmarried or living together (55.1%).
Almost half of the sample graduated fromhigh school or university
(45.9%). For patients with FM, the mean pain duration was
186.36 months (SD 5 115.14). The 2 groups did not differ in
terms of age, sex distribution, or educational level (see Table 2 for
an overview). Patients with FM reported amean pain severity level
(MPI) of 3.62 (SD 5 1.07) and mean level of restrictions in
participation (PDI) of 41.80 (SD 5 10.39). All patients with FM
fulfilled the 2010 ACR criteria58 with a mean WPI score of 11.84
(SD 5 3.33) and mean SS score of 8.96 (SD 5 1.63). Most
commonly reported pain locations were the neck (95.9%),
shoulder (left side: 89.8%, right side: 91.8%), and back (upper
back: 91.8%, lower back: 93.9%).
3.2. Task interference by pain
Before performing reaction time analyses, errors (2.7%) and outliers
were removed. Data with response latencies shorter than 200 ms
(anticipations) or 3 SDs above the individual mean reaction times of
correct responses for each trial type were considered outliers and
excluded from further analyses (1.6%). Next, a 3 (somatosensory
stimulus: nonpainful vs lowpainful vsmoderately painful)32 (Group:
patients with FM vs healthy controls) repeated-measures ANOVA
was performed. Results showed a main effect for somatosensory
stimulus (F(1.78, 170.83)5 53.50, P, 0.001, h2p 5 0.358) and Group
(F(1, 96) 5 8.07, P , 0.01, h2p 5 0.078). There was no interaction
effect (F(1.78, 170.83)5 1.60 ns; Figure 2). Planned contrasts showed
that participants were significantly slower in performing the visual
tasks when receiving moderately (M 5 735.89, SD 5 260.24)
compared with low intense painful stimuli (M 5 712.36, SD 5
234.04; F(1, 96) 5 5.43, P , 0.05, h2p 5 0.054, drm 5 0.09,
confidence interval [CI] 5 0.01-0.17). Participants were also
significantly slower to perform the visual tasks when receiving low
intense pain stimuli (M 5 712.36, SD 5 234.04) compared with
nonpainful stimuli (M5 620.53, SD 5 176.35; F(1,96)5 65.08, P,
0.001, h2p 5 0.404, drm 5 0.39, CI 5 0.29-0.49). For follow-up
correlations (section correlational analyses), an overall pain in-
terference index was calculated by subtracting the average reaction
time on nonpainful trials from themean of the average reaction times
of low and moderately painful trials. A positive index indicated
a delayed response because of the presence of pain, whereas
a negative index indicated a speeded response because of the
presence of pain.
3.3. Distraction efficacy
Analyses concerning distraction efficacy were performed on the
ratings of all correctly answered pain trials (ie, 94.1% of all
possible pain trial ratings). A 2 (Modality Relevance: somatosen-
sory relevance vs visual relevance)3 2 (Pain Stimulus: low painful
vs moderately painful) 3 2 (Group: patients with FM vs healthy
controls) repeated-measures ANOVA was performed for pain
intensity and unpleasantness. For pain intensity, a main effect
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was found for Pain Stimulus (F(1, 96) 5 66.46, P , 0.001, h2p 5
0.409, drm 5 0.13, CI 5 0.10-0.16) indicating that participants
experienced the moderately intense pain stimulus (M5 42.79, SD
5 23.73) as more painful than the low intense pain stimulus (M5
39.66, SD 5 22.64). Also, a main effect was found for Modality
Relevance (F(1, 96)5 31.31,P,0.001,h2p50.25,drm5 0.08, CI5
0.05-0.11), in that participants experienced less pain during visual
modality trials (M 5 40.29, SD 5 23.00) than during somatosen-
sory modality trials (M 5 42.15, SD 5 23.33). In contrast to our
expectation, there was no interaction effect between Group and
Modality Relevance (F(1, 96) , 1 ns). No other main effects or
interaction effects were significant (all Fs . 1.79). Results for pain
unpleasantness were similar such that there was a main effect of
Pain Stimulus (F(1,96)5 87.98, P, 0.001, h2p 5 0.478, drm5 0.16,
CI 5 0.12-0.19), indicating that participants experienced the
moderately intensepain stimulus (M5 41.63,SD5 23.55) asmore
unpleasant than the low intense pain stimulus (M 5 37.92, SD 5
22.53). In addition, we found a main effect for Modality Relevance
(F(1, 96) 5 30.91, P , 0.001, h2p 5 0.244, drm 5 0.09, CI 5 0.06-
0.12), indicating that pain was perceived as less unpleasant during
visual modality trials (M 5 38.71, SD 5 22.71) than during
somatosensory modality trials (M5 40.84, SD5 23.37). Again, in
contrast to our expectation, no interaction effect was found
between Group and Modality Relevance (F(1,96) , 1 ns). No other
main effects or interaction effects were significant (all Fs . 1). For
follow-up correlations (section correlational analyses), a distraction
efficacy index was calculated by subtracting the mean of the
average ratings on low and moderately painful visual focus trials
from that of the low and moderately painful somatosensory focus
trials for pain intensity and unpleasantness ratings, respectively.
Given that the distraction efficacy indices for pain intensity and
unpleasantness were highly correlated, an overall pain distraction
efficacy was calculated by averaging both indexes.
3.4. Correlational analyses
In a final exploratory step, we investigated whether task interference
bypain anddistractionefficacywere related. In addition,weexplored
their relationship with individual difference variables (eg, anxiety and
pain intensity). For variables measured in both groups, that is,
patients with FM and healthy controls, partial correlations were
performed to control for the impact of Group. For the variables that
were only measured in the FM patient group, Pearson correlations
were performed. Correlation analyses showed that themagnitude of
distraction efficacy and task interference by pain did not correlate (r
5 0.06 ns). Distraction efficacy was, however, negatively related to
anxiety (DASS-A, r520.18,P5 0.09), pain catastrophizing (PCS, r
5 20.18, P 5 0.08), pain severity (MPI-ps, r 5 20.26, P 5 0.07),
and fatigue at the moment of testing (fatigue, r520.25, P5 0.01),
suggesting that distraction is most effective in people who are less
anxious, are low catastrophizing about pain, report less severe pain,
or are less fatigued, respectively. By contrast, task interference by
pain was not related to any of the investigated individual difference
variables (Table 2).
4. Discussion
This study investigated task interference and distraction efficacy
in patients with FM, and in a matched healthy control group. The
results can be readily summarised. First, we found that pain
interferes with task performance in patients with FM as well as
healthy individuals. Second, participants experienced the pain
stimulus as less intense when directing attention away from the
pain stimulus (ie, when performing a visual task) than when
focusing on the pain. In contrast to our hypothesis, no difference
was found in the magnitude of the interference effect and
distraction efficacy between patients with FM and healthy
controls. Finally, our findings indicate that the indices of task
Table 1
Descriptive statistics per group (patients with FM and control group).
Healthy controls (n 5 49) Patients with FM (n 5 49) Group difference statistics
Sex (females/males) 40/9 41/8 x2(1) 5 0.07 ns
Age 45.39 (12.07) 45.20 (9.35) t(90.34) 5 0.08 ns
Education level (primary/lower secondary/higher
secondary/higher education)
2/2/19/26 2/7/21/19 x2(3) 5 3.97 ns
Pain intensity (test moment) 2.10 (4.59) 44.08 (21.06) t(52.56) 5 13.64, P , 0.001
PCS 9.88 (9.76) 21.90 (10.77) t(96) 5 5.79, P , 0.001
DASS-A 2.84 (3.48) 11.41 (7.42) t(68.21) 5 7.32, P , 0.001
DASS-D 5.61 (6.25) 13.41 (10.72) t(77.27) 5 4.40, P , 0.001
DASS-S 7.76 (7.24) 15.55 (7.81) t(96) 5 5.12, P , 0.001
BVS 14.19 (6.81) 18.59 (6.71) t(96) 5 3.22, P , 0.01
BVS, Body Vigilance Scale; DASS, Depression Anxiety Stress Scale; FM, fibromyalgia; PCS, Pain Catastrophizing Scale.
Table 2
Partial correlations controlled for group (patients with FM vs control group).
Group Dis. eff. DASS-A DASS-D DASS-S MPI-ps PCS PDI BVS State PI State fatigue
Task interference r 0.06 0.08 0.02 20.03 20.09 20.01 20.19 20.01 20.11 20.12
df 95 95 95 95 47 95 47 95 95 95
Distraction effect r 2 20.18t 20.10 20.01 20.26t 20.18t 20.19 20.10 20.14 20.25*
df 2 95 95 95 47 95 47 95 95 95
For the MPI and PDI which were only assessed in the patient with FM sample, Pearson correlations are reported tp ,.10; *p ,.05.
BVS, Body Vigilance Scale; DASS, Depression Anxiety Stress Scale; FM, fibromyalgia; MPI-ps, Multidimensional Pain Inventory pain severity; PCS, Pain Catastrophizing Scale, PDI, Pain Disability Index; PI, pain intensity.
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interference and distraction efficacy are not related to each other,
suggesting that they are not 2 sides of the same coin.
In line with previous research, the current findings show that
pain interferes with task performance in both healthy partic-
ipants35,36 and patients with chronic pain.14 Indeed, partic-
ipants’ performance on a visual detection task was significantly
slowed when receiving a painful in comparison with a nonpainful
tactile stimulus. Furthermore, to the best of our knowledge, the
current study is one of the first to show that the interference
effect increases with the intensity of the pain stimulus. This
finding is in line with earlier theories that state that salient
stimuli—that is, stimuli which are more intense, more threaten-
ing, more novel, or less predictable—are more likely to capture
attention.15,29
Furthermore, the findings of the current study indicate that
distraction from pain may result in reduced experience of a low to
moderately intense pain stimulus. Yet, the efficacy of the
distraction task was not dependent on the intensity of the pain
stimulus. This finding seems to be in contrast with research
suggesting that distraction is more effective for less intense
pain.33,54 It is, however, possible that the difference in the
intensity of the pain stimuli (low vs moderately painful) was too
small to show the impact of pain intensity on distraction efficacy. It
may also be that there is no linear relationship between pain
intensity and distraction efficacy, but that distraction is successful
until pain intensity exceeds a certain level of intensity.52 Contrary
to our expectations, groups did not differ in the magnitude of the
pain interference effect and distraction efficacy. Although the
overall performance of patients with FM was slowed,
the interference effect of low and moderately intense pain stimuli
did not differ from the interference effect in healthy controls. This
finding challenges the idea that painful stimuli more easily
demand attention in patients with FM than in healthy people.
Instead, our results suggest that patients with FM and healthy
volunteers may have similar difficulties performing a primary task
when experiencing pain.We did observe a general slowing in task
performance in patients with FM compared with healthy
participants. This is in line with previous research revealing
slower reaction times in patients with chronic pain than in healthy
controls.55 There may be several reasons for this slowed
performance. First, the slowed performance may reflect impaired
mental processing speed.20,30 Second, it is possible that the
slower reaction times can be attributed to motor slowing. Indeed,
performing the visual detection task required also a motor
response (button press). Slowed motor responses may, for
example, be due to the use of medication (or medication history)
or reduced general physical fitness levels.13 Unfortunately, the
current study does not enable us to draw firm conclusions about
whether the slow response times were due to problems in mental
processing or motor speed, or both.
The current findings suggest that distraction is as effective in
patients with FM as it is in healthy people. This finding contradicts
some earlier findings (for an overview54) indicating that distraction
is not effective or to a lesser extent in patients with chronic pain
compared with healthy controls. A number of reasons may
explain this discrepancy. First, in contrast to most distraction
studies in patients with chronic pain,22 the experimental pain
stimulus was of a short duration and of low to moderate intensity.
It may well be that patients with FM are able to increase their effort
in a distraction task for a short timespan when pain is not too
intense (see also Ref. 54). Second, our control condition did not
instruct participants to cope with pain as usual, often the case in
previous distraction research in patients with chronic pain,
allowing for large variability in used strategies21,22 (but see also
Ref. 45 for an exception). Instead, participants were instructed to
focus their attention on the pain stimuli (ie, perform a somatosen-
sory detection task). The fact that the difference in control
condition could explain these diverging findings is in line with
subanalyses of a recent meta-analysis.54 Results of this meta-
analysis showed that, although distraction shows to be ineffective
when compared with a no-instruction control condition, it does
result in a pain reduction when being compared with a condition
in which attention is focused on pain. A potential avenue for
research is then to investigate to what extent patients with FM
spontaneously make use of distraction strategies, and the
possible reasons for not doing so. All in all, this finding points at
the importance of well thought control conditions in distraction
research. Third, it should be noted that although all participants
experienced the pain stimuli as moderately painful, the stimulus
intensity was substantially lower in patients with FM compared
with their healthy counterparts. This finding is in line with the
central sensitisation hypothesis, which suggests that the re-
sponsiveness of central neurons to input from unimodal and
polymodal receptors is augmented in patients with FM, and
results in generalized or widespread hypersensitivity.34,38 The
procedure followed in the current study, to determine individual
pain thresholds, differs from most previous distraction studies in
patients with chronic pain, in that they mostly used a fixed
stimulus intensity for all participants.21 It may thus be that in
current study, distraction was equally effective in patients with FM
and healthy controls because during the calibration phase, we
identified in each individual the intensity that was experienced as
moderately painful. Therefore, at the start of the study, the self-
reported intensity of the stimulus was not different between the
FM and healthy controls. This approach was deliberate. When
using a stimulus of fixed intensity,21,22 experienced pain may be
higher in patients with FM than in healthy controls because of
differences in low level processes involved in peripheral or central
sensitisation. During the calibration phase, we instructed
participants to pay close attention to the stimulus. That way, we
reasoned that attention to pain was kept constant, and potential
differences in the way participants habitually pay attention to pain
were ruled out.1 Future work should further explore this
assumption. Finally, we found that the magnitude of task
interference by pain is not related to distraction efficacy. This
finding suggests that distraction efficacy is not just the
counterpart of task interference by pain.50 Distraction efficacy is
based on self-report of pain and may be more prone to
expectations of people and/or reporting or reflection biases. This
may also explain why only distraction efficacy, and not task
Figure 2. Task interference effect per group (patients with FM vs control
group). FM, fibromyalgia.
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interference, was related to self-report measures of pain
experience, catastrophizing, anxiety, and levels of fatigue in
patients with FM.
In addition to these theoretical implications, the current findings
also have clinical implications. On the one hand, our results
indicate that under specific conditions, distraction may be useful
in patients with FM. That is, when pain is not intense and of short
duration. It should be noted that our cognitive distraction task only
resulted in a small reduction in self-reported pain. As such, the
use of distraction strategies should be well considered. On the
other hand, our results also show that distraction may be less
effective for patients with FM who experience more intense
chronic pain, catastrophize about their pain, and are more
anxious or more fatigued.
This study has some limitations. First, the current study was
performed in the laboratory using experimental pain stimuli.
Although the use of experimental pain stimuli increases exper-
imental control, it may be difficult to generalize findings to the
everyday life of patients with FM. Second, we opted to tailor the
intensity of the experimental pain stimulus to an experience of
moderate pain. This resulted in the presentation of pain stimuli,
which differed in their (objective) intensity. Other studies have
most often used a fixed intensity procedure. Our resultsmay differ
from these studies because of this dissimilarity. Third, we did not
assess whether the tactile stimulus was perceived as painful by
the patients with FM. This is, however, unlikely because no patient
mentioned that the tactile stimulus was perceived as painful and
unpleasantness ratings of the tactile stimulus were low. There
was also no difference in the unpleasantness ratings between
patients with FM and healthy participants. Fourth, the difference
between low intensity and moderate intensity pain stimuli was
relatively small. This may have reduced the chances to find an
impact on distraction efficacy. Future research may opt to
increase the difference between the intensity levels of pain stimuli.
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